CONTENTS:
• Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: A looming public health concern? Kanayama G., Hudson J.I., Pope H.G., Jr., p. 1-12.
• Meta-analysis of depression and substance use and impairment among cocaine users. Conner K.R., Pinquart M., Holbrook A.P., p. 13-23.
• Among long-term crack smokers, who avoids and who succumbs to cocaine addiction? Falck R.S., Wang J., Carlson R.G., p. 24-29.
• Genome-wide linkage analysis of heroin dependence in Han Chinese: Results from Wave Two of a multi-stage study. Glatt S.J., Lasky-Su J.A., Zhu S.C., Zhang R., Zhang B., Li J., et al., p. 30-34.
• Partner aggression among men and women in substance use disorder treatment: Correlates of psychological and physical aggression and injury. Chermack S.T., Murray R.L., Walton M.A., Booth B.A., Wryobeck J., Blow F.C., p. 35-44.
• The role of medical conditions and primary care services in 5-year substance use outcomes among chemical dependency treatment patients. Mertens J.R., Flisher A.J., Satre D.D., Weisner C.M., p. 45-53.
• Disparate cocaine-induced locomotion as a predictor of choice behavior in rats trained in a delay-discounting task. Stanis J.J., Burns R.M., Sherrill L.K., Gulley J.M., p. 54-62.
• Replication and sustainability of improved access and retention within the Network for the Improvement of Addiction Treatment. Hoffman K.A., Ford J.H., 2nd, Choi D., Gustafson D.H., McCarty D., p. 63-69.
• Dopamine transporter levels in cocaine dependent subjects. Crits-Christoph P., Newberg A., Wintering N., Ploessl K., Gibbons M.B., Ring-Kurtz S., et al., p. 70-76.
• Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: New data from the Patch in Practice trial and pooled analyses. David S.P., Johnstone E.C., Murphy M.F., Aveyard P., Guo B., Lerman C., et al., p. 77-85.
• A placebo-controlled trial of modafinil for nicotine dependence. Schnoll R.A., Wileyto E.P., Pinto A., Leone F., Gariti P., Siegel S., et al., p. 86-93.
• Developmental trajectories of criteria of nicotine dependence in adolescence. Hu M.C., Muthen B., Schaffran C., Griesler P.C., Kandel D.B., p. 94-104.
• Using a factor mixture modeling approach in alcohol dependence in a general population sample. Kuo P.H., Aggen S.H., Prescott C.A., Kendler K.S., Neale M.C., p. 105-114.
• Treatment-naive active alcoholics have greater psychiatric comorbidity than normal controls but less than treated abstinent alcoholics. Di Sclafani V., Finn P., Fein G., p. 115-122.
• Generalizability of clinical trials for alcohol dependence to community samples. Blanco C., Olfson M., Okuda M., Nunes E.V., Liu S.M., Hasin D.S., p. 123-128.
• Aerobic exercise decreases the positive-reinforcing effects of cocaine. Smith M.A., Schmidt K.T., Iordanou J.C., Mustroph M.L., p. 129-135.
• The developmental origin of adolescent alcohol use: Findings from the Mater University Study of Pregnancy and its outcomes. Alati R., Clavarino A., Najman J.M., O'Callaghan M., Bor W., Mamun A.A., et al., p. 136-143.
• Ethnic differences in HIV risk behaviors among methadone-maintained women receiving contingency management for cocaine use disorders. Barry D., Weinstock J., Petry N.M., p. 144-153.
• Use of nicotine replacement therapy among never smokers in the 1999-2006 National Health and Nutrition Examination Surveys. Gerlach K.K., Rohay J.M., Gitchell J.G., Shiffman S., p. 154-158.
• Accessing care for injection-related infections through a medically supervised injecting facility: A qualitative study. Small W., Wood E., Lloyd-Smith E., Tyndall M., Kerr T., p. 159-162.
• Choice of nitrous oxide and its subjective effects in light and moderate drinkers. Zacny J.P., Walker D.J., Derus L.M., p. 163-168.